equitybuy

LHX

Trust-weighted public proof page for LHX. See which authors support it, which ticker theses it belongs to, and how thesis calls have performed.

Opportunity
235 / 100
Current score
4.15
Thesis calls
7
Active decisions
9

Recent proof-backed thesis calls

Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.

Discussion frames space as increasingly central to modern warfighting and highlights Lockheed Martin’s long-standing UK presence/partnership, while noting an EU/“made in Europe” procurement push that could influence competitive positioning for defense/space contracts.

Mentioned: Jul 21, 2026, 1:35 PM EDTConviction: 45 / 100
Source: Lockheed's Martin Says Space Is Now Key to Warfighting Plans

Discussion highlights concerns about Patriot/PAC-3 interceptor stockpiles and multi-year replenishment timelines, implying pressure to accelerate production and procurement. It also flags a pivot toward lower-cost air defense/drone solutions and directed-energy (lasers) as a capability gap-filler, plus incremental support for UK defense spending and UK-Ukraine drone innovation.

Mentioned: Jul 11, 2026, 12:59 PM EDTConviction: 54 / 100
Source: Ukraine Seeks Faster Patriot Production

A qualitative thesis: in a chaotic/progressive world, static planning/fortifications are less useful than investing in faster command/control systems and shortening decision/response loops (OODA). Implies relative preference for adaptive control, automation, real-time intelligence, and resilient communications over rigid, long-cycle planning projects.

Mentioned: Jun 17, 2026, 11:07 PM EDTConviction: 53 / 100
Source: Pinned ivan @IvanVendrov Nov 13, 2022 Von Neumann on existential risk: Progress is chaotic so investments in planning...

The provided text is only the cover page of L3Harris Technologies’ (LHX) Form 10‑Q for the quarter ended April 3, 2026. It confirms the filing occurred and the company remains listed and compliant with required SEC reporting/interactive data file submissions, but contains no financial results, guidance, risks, backlog, segment performance, or management commentary. Actionability is therefore very limited from this excerpt alone.

Mentioned: Apr 30, 2026, 2:32 PM EDTConviction: 25 / 100
Source: LHX 10-Q report for 2026-04-03

The provided text is only the header portion of L3Harris Technologies’ (LHX) Form 10-K for fiscal year ended Jan 2, 2026 and does not include financial results, guidance, segment performance, backlog, risk factors, or MD&A. As shown, it confirms LHX is a NYSE-listed issuer and that a 10-K was filed/issued, but contains no incremental disclosures to trade on from this excerpt alone.

Mentioned: Feb 12, 2026, 12:46 PM ESTConviction: 25 / 100
Source: LHX 10-K report for 2026-01-02

The provided text is only the cover/header portion of L3Harris Technologies’ Form 10‑Q for the quarter ended Oct 3, 2025 (filing compliance/check-boxes, exchange listing, basic identifiers). It contains no financial statements, MD&A, guidance, risk updates, segment results, backlog, cash flow, or notable disclosures. As-is, it is not sufficient to form an evidence-based bullish/bearish view or a high-confidence trade beyond noting a routine SEC filing event.

Mentioned: Oct 30, 2025, 12:18 PM EDTConviction: 60 / 100
Source: LHX 10-Q report for 2025-10-03

This excerpt is only the cover/header page of L3Harris Technologies, Inc. (LHX) Form 10‑Q for the quarter ended June 27, 2025. It contains no financial statements, MD&A, guidance, segment results, risks, or other disclosures that would support a directional investment view.

Mentioned: Jul 24, 2025, 12:00 PM EDTConviction: 60 / 100
Source: LHX 10-Q report for 2025-06-27

Current stance

Recommendationbuy
Authors3
Active decisions9
Latest pricen/a

Investment decisions

LHX
research_buy

LHX
watch

LHX
watch

LHX
risk_review

LHX
research_buy

LHX
research_buy

LHX
research_buy

LHX
research_buy

LHX
research_buy

LHX
risk_review

Unlock full asset monitoring

Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.